Spruce Biosciences SPRB
NASDAQ SPRB
$47.27 -0.24 (-0.51%)
At close: Sep 29, 2026 · 4:00 PM EDT

Spruce Biosciences (SPRB) Receivables (2023)

Updated

Spruce Biosciences (SPRB) reported Receivables of $15 million for Q1 2023.

Analysis

Spruce Biosciences (SPRB) Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Spruce Biosciences 130.79 Mn 130.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 15.00 Mn
API Access

Spruce Biosciences Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=SPRB&period=max&api_key=YOUR_API_KEY